Urokinase-like plasminogen activator as a marker of endometrial neoplasia
- 15 September 1981
- Vol. 48 (6) , 1484-1486
- https://doi.org/10.1002/1097-0142(19810915)48:6<1484::aid-cncr2820480634>3.0.co;2-l
Abstract
Urokinase-like plasminogen activator (ULPA) was determined with a radioimmunoassay in uterine aspirates from 67 patients prior to curettage. In women with normal endometrial histology the mean concentration of ULPA was 5.4 ± 2.5 m̈g per liter. Only one of this aspirates contained more than 8 m̈g per liter. In cases with malignant histology ULPA was above this level in 10 of 11 with a mean concentration of 31.2 ± 31.4 m̈g per liter. In cases with glandular cystic hyperplasia and/or adenomatous hyperplasia 6 of 15 had values above 8 m̈g per liter with a mean of 10.3 ± 6.1 m̈g per liter. In addition to other parameters of malignancy such as cytology, detection of ULPA in uterine fluid might prove useful in screening examinations for endometrial neoplasia.This publication has 18 references indexed in Scilit:
- Release of plasminogen activator from normal and neoplastic endometriumCellular and Molecular Life Sciences, 1979
- Immunohistochemical Demonstration of Several Tumour Markers in Neoplastic and Preneoplastic States of the Uterine MucosaGynecologic and Obstetric Investigation, 1978
- Purification of urokinase by affinity chromatographyBiochimica et Biophysica Acta (BBA) - Enzymology, 1976
- Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue cultureNature, 1976
- Cytoenzymology of benign and malignant tumours of the corpus uteriActa Histochemica, 1976
- Biochemical parameters of abnormal endometriumGynecologic Oncology, 1974
- SECRETION OF PLASMINOGEN ACTIVATOR BY STIMULATED MACROPHAGESThe Journal of Experimental Medicine, 1974
- Plasminogen-activator-producing TumourBMJ, 1969
- On the use of fibrinolysin inhibitors in plasma clot tissue cultureExperimental Cell Research, 1960
- Mechanism of the Proteolytic Activity of Malignant Tissue CellsNature, 1946